Skip to main content

Degradation and Stabilization of Peptide Hormones in Human Blood Specimens.

Yi J, Warunek D, Craft D

Publication: PLoS One (2015) • Vol 10 • Page e0134427PMID: 26222180View on PubMed

Purpose

The purpose of this paper was to assess the stability of the active forms of select circulating peptide gut hormones (glucagon-like peptide 1, GLP-1;  glucose-dependent insulionotropic polypeptide, GIP; oxyntomodulin, OXM), and glucagon ) in whole blood, serum, and plasma collected and stored pre- or post-centrifugation in tubes containing different anticoagulants with or without protease inhibitors.

Conclusion

Evidence of proteolytic activity was observed in serum, EDTA-, citrate- and heparin-plasma after a post-centrifugation delay at room temperature.  Incubating EDTA plasma on wet ice as opposed to room temperature during the delay only partially attenuated the effects of the post-centrifugation delay on GIP-1 levels. However, all peptide gut hormones were stable for up to 72 h at room temperature in plasma from P800 tubes that contained a proprietary protease inhibitor cocktail. A pre-centrifugation delay also resulted in declines in GIP-1 among non-anticoagulated blood and EDTA plasma stored on wet ice or at room temperature.  In response to a pre-centrifugation delay, GLP-1 levels also declined in plasma when  blood was collected in P800 tubes, however the declines were more modest and calculated half-life was much longer than were observed for blood collected in EDTA tubes (>72 h vs. 20.6 h).  The authors conclude that proteases remain active in blood-derived specimens both before and after centrifugation, and can only be attenuated by the inclusion of protease inhibitors in the blood collection tube.

Studies (2)

Purpose

The purpose of this paper was to assess the post-centrifugation stability of the active forms of select circulating peptide gut hormones in serum, and plasma collected using different anticoagulant with and without protease inhibitors . Blood was collected from at least six healthy volunteers into different tube types, centrifuged for 15 min for 2,500 x g, and then 10 µl from each patient was pooled in a new tube that was then spiked with the target peptide. The pooled, spiked specimen was  then subjected to a room temperature delay of 0-96 h in a temperature controlled chamber or on ice. Specimens were analyzed immediately or frozen at -80°C. Peptide targets included glucagon-like peptide 1 (GLP-1),  glucose-dependent insulionotropic polypeptide (GIP), oxyntomodulin (OXM), and glucagon.

Summary of Findings

In EDTA plasma active forms of GLP-1 (G36A, G37) began to decline after a post-centrifugation delay of 4 h at room temperature, which corresponded to an increase in abundance of their respective fragments (G36A-2N, G37-2N).  The increase in G36-2N and G37-2N, which are both lacking two N-terminal residues, suggests that DPP-IV remains active in centrifuged EDTA plasma. However, subsequent declines in G36-2N and G37-2N signal intensities in EDTA plasma after 72 h at room temperature, indicated other peptidases are also active. Similar GLP-1 stabilities  were reported for  citrate- and heparin-plasma, as well as GIP in serum specimens compared to that of EDTA plasma. Inclusion of a protease inhibitor cocktail optimized to target DD-IV and other peptidases in blood collection tubes (P700 and P800 tubes) served to stabilize GLP-1 active forms G36A and G37, delaying their decline and the appearance of their fragments (G36A-2N and G37-2N) until 72 h. The calculated half-life of G36A was extended from 6 h in EDTA plasma to >96 h when the protease inhibitor was included (B700 and B800 tubes). ELISA targeting G36A confirmed mass spectrometry findings, as its concentration remained stable for 72 h in plasma collected in B700 or B800 tubes compared to EDTA plasma that exhibited a decline within 5 h.  The authors note the decline in G36A in EDTA plasma occurred rapidly, dropping to 50% of the concentration observed in B800 tubes within 20 min.  This decline was partially attenuated when EDTA plasma was stored on ice during the post-centrifugation delay, reducing the magnitude of decline to 20% with a 20 min delay, and extending the projected half-life to 15 h. Comparable results were obtained regardless of whether P800 plasma was stored on wet ice or at room temperature during the post-centrifugation delay.   Similar trends were observed for other peptides (oxyntomodulin, OXM; glucagon) cleaved from the same protein (proglucagon).  The active form of OXM began to decline after a 24 h post-centrifugation delay, which coincided with the first appearance of its fragment in EDTA plasma, while levels of OXM in P800 plasma remained stable for 72 h.  The calculated half-life of glucagon was longer in P800 compared to EDTA plasma tubes, increasing from 20.4 h to 45.6 h.

  • Biospecimens

    FluidPlasma
    FluidSerum
  • Preservation Types

    Frozen
  • Diagnoses

    Normal
  • Platforms

    PeptideMALDI-TOF MS
    PeptideImmunoassay
    PeptideRadioimmunoassay
  • Pre-analytical Factors

    ClassificationPre-Analytical FactorValue(s)
    Biospecimen AcquisitionAnticoagulant
    Citrate
    EDTA
    Heparin
    None
    Biospecimen AcquisitionType of collection container/solution
    Citrate
    EDTA
    Heparin
    P700
    P800
    StorageStorage duration
    0 h
    1 h
    12 h
    2 h
    24 h
    4 h
    48 h
    6 h
    74 h
    96 h
    StorageStorage temperature
    Room temperature
    Wet ice
    Analyte Extraction and PurificationProtease inhibitor
    Cocktail
    No protease inhibitor added